Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combizym in the prevention of aged functional dyspepsia
ChiCTR-IPR-16008023Phase 4Not yet recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Apr 2016
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of Aspergillus oryzae + Pancreatin in functional dyspepsia (FD) (3 arms), sponsored by Chinese PLA General Hospital. Primary endpoints: Epigastric pain, Epigastric discomfort and 14 more. Planned start Apr 2016; status: not yet recruiting.
02
Drugs
Aspergillus oryzae + Pancreatin
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ChiCTR-IPR-16008023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008023.